Tyers Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.41M Sell
174,244
-79,744
-31% -$1.46M 0.11% 152
2019
Q2
$4.43M Sell
253,988
-37,296
-13% -$672K 0.15% 130
2019
Q1
$5.39M Sell
291,284
-95,844
-25% -$1.71M 0.19% 112
2018
Q4
$6.22M Buy
387,128
+4,648
+1% +$73.5K 0.25% 87
2018
Q3
$5.7M Buy
382,480
+224,588
+142% +$3.28M 0.19% 119
2018
Q2
$2.22M Buy
157,892
+118,356
+299% +$1.57M 0.08% 203
2018
Q1
$514K Buy
39,536
+476
+1% +$6.09K 0.02% 407
2017
Q4
$538K Buy
39,060
+8,372
+27% +$113K 0.02% 421
2017
Q3
$403K Buy
30,688
+4,116
+15% +$53K 0.01% 453
2017
Q2
$342K Buy
26,572
+13,104
+97% +$174K 0.01% 497
2017
Q1
$174K Buy
13,468
+784
+6% +$10K 0.01% 554
2016
Q4
$156K Buy
+12,684
New +$164K 0.01% 547

Other funds holding MPT

Tyers Asset Management's MPT Position: Q3 2019 in Review

Tyers Asset Management reduced its Medical Properties Trust (MPT) stake by 31% in Q3 2019, selling an estimated $1.46M and leaving 174,244 shares worth $3.41M. The position accounts for 0.11% of the portfolio, ranked #152.

Tyers Asset Management first reported a position in MPT in Q4 2016 and has held it in 12 quarters since. The position peaked at $6.22M in Q4 2018. 454 funds tracked by Wall St. Rank hold MPT as of Q3 2019.

  • Tyers Asset Management held 174,244 shares of Medical Properties Trust worth $3.41M as of Q3 2019.
  • Tyers Asset Management sold 79,744 Medical Properties Trust shares in Q3 2019, an estimated $1.46M.
  • Medical Properties Trust made up 0.11% of Tyers Asset Management's portfolio in Q3 2019, its #152 holding.
  • Tyers Asset Management first reported a position in Medical Properties Trust in Q4 2016 and has held it in 12 quarters since.
  • Tyers Asset Management's Medical Properties Trust position peaked at $6.22M in Q4 2018.
  • 454 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.